Affinity Asset Advisors, LLC Options Holdings

Affinity Asset Advisors, LLC

  • $596 Million
  • Q2 2025

Options Holdings Table

Stock Option Type Value Options Held Last Trade Trade History
EXEL
Exelixis, Inc.

Healthcare
PUT
$19.8 Million
450K
Q2 2025
New holding
AMGN
Amgen Inc

Healthcare
CALL
$11.2 Million
40K
Q2 2025
Reduced 42.86%
CRSP
Crispr Therapeutics Ag

Healthcare
CALL
$9.73 Million
200K
Q2 2025
New holding
EXEL
Exelixis, Inc.

Healthcare
CALL
$6.61 Million
150K
Q2 2025
New holding
CAPR
Capricor Therapeutics, Inc.

Healthcare
PUT
$1.74 Million
175K
Q2 2025
New holding
NVAX
Novavax Inc

Healthcare
CALL
$1.58 Million
250K
Q2 2025
New holding
QURE
Uni Qure N.V.

Healthcare
CALL
$1.39 Million
100K
Q2 2025
New holding
OMER
Omeros Corp

Healthcare
PUT
$942,000
314K
Q2 2025
New holding
INMB
Inmune Bio, Inc.

Healthcare
PUT
$817,000
354K
Q2 2025
New holding
ALT
Altimmune, Inc.

Healthcare
CALL
$774,000
200K
Q2 2025
New holding
ABUS
Arbutus Biopharma Corp

Healthcare
CALL
$28,000
9.3K
Q2 2025
New holding
Karyopharm Therapeutics Inc
CALL
$0
158K
Q2 2025
New holding
Apogee Therapeutics Inc
PUT
$0
2.5K
Q2 2025
New holding

Summary

  • Portfolio
  • No. of Stocks 91
  • Current Value $596 Million
  • Prior Value $896 Million
  • Filing
  • Period Q2 2025
  • Filing Date August 13, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 12 stocks
  • Additional Purchases 19 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 23 stocks
Track This Portfolio

Track Affinity Asset Advisors, LLC Portfolio

Follow Affinity Asset Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Affinity Asset Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Affinity Asset Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email